cordycepin has been researched along with Bile Duct Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kaewkod, T; Panwong, S; Panya, A; Sawasdee, N; Tragoolpua, Y; Wathikthinnakon, M; Yenchitsomanus, PT | 1 |
Chen, D; Li, Y; Liu, T; Peng, B; Ren, X; Su, Z; Wang, T; Yan, W; Yang, C; Zhou, X | 1 |
Cui, M; Jin, G; Lin, Z; Liu, T; Lv, Y; Ren, X; Wang, X; Yan, W; Zhu, G | 1 |
3 other study(ies) available for cordycepin and Bile Duct Cancer
Article | Year |
---|---|
Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells.
Topics: Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Cordyceps; Deoxyadenosines; fas Receptor; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens Class I; Humans; Killer Cells, Natural; Plant Extracts; Receptors, TNF-Related Apoptosis-Inducing Ligand | 2021 |
Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Epithelial-Mesenchymal Transition; Humans; Lipid Metabolism; Mice; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma.
Topics: Animals; Bile Duct Neoplasms; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Chromosomal Proteins, Non-Histone; Deoxyadenosines; Extracellular Signal-Regulated MAP Kinases; Humans; Male; MAP Kinase Signaling System; Mice; Neovascularization, Pathologic; Oncogene Proteins; Poly-ADP-Ribose Binding Proteins; Xenograft Model Antitumor Assays | 2020 |